Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants

NCT06389513 is registered in ClinicalTrials.gov with CanSino Biologics Inc. as lead sponsor.

NCT NCT06389513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06389513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Clinical Study of the Safety of Menhycia® in 3-Month-Old Infants
Lead sponsor
CanSino Biologics Inc.
Phase
Phase 4
Overall status
Completed
Start date
June 12, 2024
Completion date
May 1, 2026
Enrollment
3,011 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epidemic meningitis